AMANDA BEEVERS: Open Payments
NPI 1487026712 · KELLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,068 in 166 payments from 35 companies in 2025. Trend: 2023 $2,761 · 2024 $2,864 · 2025 $3,068
Food & beverage: $3,068
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $451 |
| Axsome Therapeutics, Inc. | 18 | $320 |
| PFIZER INC. | 14 | $308 |
| ABBVIE INC. | 20 | $293 |
| Lilly USA, LLC | 8 | $208 |
| Corcept Therapeutics | 8 | $160 |
| AstraZeneca Pharmaceuticals LP | 4 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| Antares Pharma, Inc. | 4 | $82 |
Products named: Sunosi, Wegovy, NURTEC ODT, Ozempic, UBRELVY, Korlym, Kerendia, ELIQUIS.
Industry payments across TX — which companies pay providers there.
